April 22, 2016, the anniversary of Aly's death, a new clinical trial at the University of Wisconsin Carbone Cancer Center was approved. The trial was made possible due to support from The Aly Wolff Foundation and holds great promise in offering a new line of treatment for those with neuroendocrine tumors. This trial is now open for NET patients in the Midwest.